Omnicell
Omnicell is a public healthcare technology company providing medication management automation—including automated dispensing cabinets, central pharmacy robots, IV compounding robotics, and the OmniSphere cloud platform—to hospitals, health systems, and specialty pharmacies globally.
- Company typePublic
- Founded1992
- HeadquartersSanta Clara, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Omnicell does
Omnicell, Inc. (NASDAQ: OMCL) is a US-based healthcare technology company founded in 1992 by Randall Lipps and headquartered in Fort Worth, Texas (principal executive office), with operations across the US, UK, Germany, France, Italy, Netherlands, Australia, China, India, and the UAE. The company provides medication management automation solutions for hospitals, health systems, and specialty pharmacies, spanning automated dispensing cabinets (XT Series, Titan XT), central pharmacy robotics (XR2), IV compounding robotics (IVX Station), RFID-enabled perioperative systems (MedTrack, MedVision), and cold-chain storage (MedChill).
The technical core of the platform is OmniSphere, a HITRUST CSF i1-certified, cloud-native software workflow engine and data platform that integrates Omnicell's enterprise robotics and smart devices across care settings and connects to Epic and Cerner EHR systems via HL7/FHIR, plus DSCSA partners (TrackTraceRX, LSPedia). The product portfolio is anchored by an extensive patent estate spanning the US, Europe, China, Japan, Korea, Australia, Canada, and Singapore. Omnicell is investing in AI and machine vision through a newly opened Austin Innovation Lab and a refreshed technology leadership under CTO Perry Genova, with the stated strategic goal of enabling autonomous medication management.
Omnicell generates revenue through a mix of one-time equipment sales (automated dispensing cabinets, central pharmacy and IV compounding robots) and recurring software and services revenue, with the latter explicitly positioned as the strategic growth lever to reduce dependence on lumpy hardware cycles. Q1 2026 revenue of $310 million (+15% YoY) and service revenue of $135 million (+8% YoY) reflect this transition. Distribution is exclusively direct enterprise field sales to hospitals and health systems, with no reseller or distributor channel disclosed. The company acquired ANiGENT in 2025 and partnered with Gollmann in 2024 to broaden its automation capabilities and geographic reach.
Omnicell firmographics
Firmographics- Name
- Omnicell
- Legal name
- Omnicell, Inc.
- Website
- https://omnicell.com
- Company type
- Public
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Omnicell is a public healthcare technology company providing medication management automation—including automated dispensing cabinets, central pharmacy robots, IV compounding robotics, and the OmniSphere cloud platform—to hospitals, health systems, and specialty pharmacies globally.
- Ownership category
- akta.pro rank
Omnicell industry classification
Industry- Product category
- Pharmacy Automation and Medication Management
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
- akta.pro secondary industry
- Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)
Keywords
Where Omnicell is headquartered
LocationHeadquarters
- HQ city
- Santa Clara
- HQ country
- United States
- HQ region
- North America
Offices18 records
Markets served
Omnicell business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Revenue model
- Automated Dispensing Cabinets: One-time equipment sales of automated dispensing cabinets (XT Series) sold to hospitals and health systems. This is the historical core of the business.
- Central Pharmacy Robots: Sale of central pharmacy robotic systems including XR2 for medication dispensing automation.
- Software (SaaS): Software sold to hospitals and health systems including cloud-based OmniSphere platform, MedVision, and analytics tools. The company is actively pursuing strategy to increase recurring software and services revenue to reduce dependence on one-time equipment sales.
- Services and Technical Services: Service revenue including technical services, training, and support for installed base. Q1 2026 service revenue was $135 million, up 8% year-over-year.
- Connected Devices: Connected smart devices including dispensing cabinets and other smart devices that integrate with the OmniSphere platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise hardware and software solutions sold via direct sales to healthcare organizations |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
Omnicell product offering
Product offeringCore offering
Omnicell designs, manufactures, and sells automated medication management solutions to hospitals and health systems, including automated dispensing cabinets (XT Series, Titan XT), central pharmacy robots (XR2), robotic IV compounding systems (IVX Station), RFID-enabled smart devices, and the cloud-native OmniSphere software platform. The company also provides managed services (Central Pharmacy Dispensing Service, IV Compounding Service, Specialty Pharmacy Services, 340B program management) and patient engagement tools through its EnlivenHealth brand.
Product overview
Omnicell offers a unified portfolio of medication management products organized around the Autonomous Pharmacy vision — combining robotics (XR2, IVX Station, Titan XT), smart devices (XT Automated Dispensing Cabinets, XT Anesthesia Workstation, MedChill, MedTrack RFID), and intelligent software (OmniSphere cloud platform, MedVision, MedXpert, Insights) across all care settings (Inpatient: IV Room, Central Pharmacy, Points of Care; Outpatient: Specialty Pharmacy, Retail Pharmacy, Medication Adherence). The core platform is OmniSphere, a cloud-native workflow engine that unifies enterprise robotics and smart devices, providing real-time inventory visibility and analytics. Services include Central Pharmacy Dispensing Service (CPDS), IV Compounding Service (IVCS), Inventory Optimization Service, Specialty Pharmacy Services, 340B program management, and EnlivenHealth patient engagement solutions. Omnicell's Austin Innovation Lab drives next-generation AI and robotics development. The company also acquired ANiGENT in 2025 to expand its pharmacy automation capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- OmniSphere: Next-generation cloud native software workflow engine and data platform for enterprise medication management
- Titan XT
- XR2
- IVX Station
- MedVision
- MedChill
- EnlivenHealth
- ANiGENT
- XT Series
Products and services
- Titan XT Automated Dispensing System Enterprise-level automated medication dispensing system (ADC) for points of care, combining proven automation with powerful intelligence to deliver enhanced medication management. Omnicell's first major automated dispensing cabinet refresh since 2017.
- OmniSphere Cloud Platform Cloud-native software workflow engine and data platform that integrates enterprise robotics and smart devices across all healthcare settings, providing real-time inventory visibility, analytics, and enterprise-wide medication control across central pharmacy, IV room, and points of care.
- XR2 Automated Central Pharmacy System
Quantifiable outcome
- Baptist Health Alabama achieved $425,000 in savings with intelligent inventory solutions
- +3 more outcomes
Companies that use Omnicell
Customer profileNamed customers19 records
Segments5 records
Ideal customer profiles2 records
Omnicell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability7 records
Feature8 records
Omnicell partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Evoke Pharma / EVERSANAminorOmnicell relationship with Evoke Pharma and EVERSANA expands GIMOTI access to gastro health and large GI practices through specialty pharmacy and 340B services.
- ANiGENTcoreOmnicell acquired ANiGENT, expanding its portfolio of pharmacy automation solutions and capabilities in medication management.
- Gainsight (Customer Community)minorGainsight provides and manages Omnicell's customer community web forum, including content moderation services.
- GollmannminorOmnicell and Gollmann joined forces to revolutionize pharmacy automation, combining complementary technologies and market presence in the pharmacy automation space.
- TrackTraceRXcoreTrackTraceRX collaboration with Omnicell launched a new pharmacy inventory tracking interface designed to support DSCSA (Drug Supply Chain Security Act) compliance and strengthen pharmacy supply chain security. The interface integrates with OmniSphere platform.
- LSPediacoreLSPedia collaboration with Omnicell provides DSCSA-compliant interfaces integrated with OmniSphere platform for pharmacy supply chain security and regulatory compliance.
Scale indicators18 records
Recent moves7 records
Expansion highlights7 records
Omnicell competitors and assessment
Company assessmentDirect peers
- Becton, Dickinson and Company (BD): BD's Pyxis product line directly competes with Omnicell's XT automated dispensing cabinets and central pharmacy automation in the same hospital and health system accounts, making it the most direct peer in medication management.
- Capsa Healthcare: Capsa Healthcare builds automated dispensing cabinets, medication carts and pharmacy workflow solutions that overlap directly with Omnicell's XT cabinet and point-of-care dispensing portfolio.
- ScriptPro: ScriptPro provides pharmacy robotics, dispensing automation and medication management software for retail and hospital pharmacies, competing with Omnicell's central pharmacy and retail pharmacy automation offerings.
- Swisslog Healthcare: Swisslog Healthcare offers hospital pharmacy automation solutions including centralized pharmacy robots and packaging systems that compete with Omnicell's XR2 and IVX Station in inpatient pharmacy workflows.
- ARxIUM (now part of Becton Dickinson): ARxIUM's pharmacy automation solutions (central pharmacy robots and workflow software) competed directly with Omnicell's XR2 and IVX systems before being folded into BD's medication management portfolio.
Broad incumbents
- Oracle Health (formerly Cerner): Oracle Health's EHR and medication management modules integrate with hospital pharmacy workflows and compete at the software layer with OmniSphere, while also partnering via HL7/FHIR for ADCs and pharmacy automation.
- Baxter International: Baxter operates broadly across medication delivery, IV solutions and hospital pharmacy, overlapping with Omnicell's IV compounding and sterile preparation portfolio as part of a much wider medical products business.
- McKesson: As the largest pharmaceutical distributor with extensive specialty pharmacy and 340B services, McKesson competes with Omnicell's Specialty Pharmacy Services and broader medication management footprint across health system customers.
Others
- Health Robotics (now part of Omnicell-related ecosystem): Health Robotics (originally an independent IV compounding robotics vendor, whose technology traces into today's IVX/APOTECA ecosystem) is adjacent technology that historically competed with Omnicell's sterile compounding line.
Emerging players
- Talis Clinical: Talis Clinical offers IV infusion workflow and medication safety software that overlaps with Omnicell's IVX Station and IV Compounding Service in the high-acuity IV room segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Omnicell social profiles
Digital presenceOmnicell compliance and trust
Trust signalCompliance8 records
Omnicell financial estimates
Financial estimateRevenue estimate
Valuation estimate
Omnicell leadership team
Management profileNumber of profiles
Profiles14 records
Omnicell subsidiaries and ownership
Company hierarchySubsidiaries1 record
Omnicell funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Omnicell M&A and investment
M&A and investmentM&A6 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Omnicell
What does Omnicell do?
Omnicell designs, manufactures, and sells automated medication management solutions to hospitals and health systems, including automated dispensing cabinets (XT Series, Titan XT), central pharmacy robots (XR2), robotic IV compounding systems (IVX Station), RFID-enabled smart devices, and the cloud-native OmniSphere software platform. The company also provides managed services (Central Pharmacy Dispensing Service, IV Compounding Service, Specialty Pharmacy Services, 340B program management) and patient engagement tools through its EnlivenHealth brand.
Is Omnicell a public or private company?
Omnicell is a public company. It is classified as public and is currently operating.
When was Omnicell founded?
Omnicell was founded in 1992. It employs 1,001 to 5,000 people.
Where is Omnicell based?
Omnicell is headquartered in Santa Clara, United States, in the North America region.
How does Omnicell make money?
Five revenue lines are on record. Automated Dispensing Cabinets are the primary driver. The others are central Pharmacy Robots, software (SaaS), services and Technical Services and connected Devices.
Who are Omnicell's main competitors?
Direct peers on record are Becton, Dickinson and Company (BD), Capsa Healthcare, ScriptPro, Swisslog Healthcare and ARxIUM (now part of Becton Dickinson). Broad incumbents are Oracle Health (formerly Cerner), Baxter International and McKesson. Health Robotics (now part of Omnicell-related ecosystem) is listed as an others. Talis Clinical is listed as an emerging player.
Does Omnicell have an API?
No public API is recorded for Omnicell.
What industry is Omnicell in?
Omnicell's product category is Pharmacy Automation and Medication Management. Its primary akta.pro industry code is HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools, with a secondary code of HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers). Its NAICS code is 339112 and its SIC code is 3841.